SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Chris Kay
Stay informed with Chris Kay’s coverage and analysis for Fortune.
Health
A Sinopharm booster generates ‘significantly lower’ levels of antibodies against Omicron, according to a new study
By
Chris Kay
and
Bloomberg
International
India drops COVID travel restrictions for vaccinated tourists from 99 countries after 20 months
By
Chris Kay
and
Bloomberg
International
WHO grants emergency authorization to India’s COVID-19 vaccine Covaxin
By
Chris Kay
,
Corinne Gretler
, and others
Health
COVID is deadlier in Brazil—and nobody knows why
By
Chris Kay
,
Andre Romani Pinto
, and others